TD Cowen on DexCom (DXCM): 'G7 Angst Has Created Attractive Risk/Reward Setup Into Q3 Print'
Tweet Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $100.00 price target on DexCom (NASDAQ: DXCM).The analyst commented: "G7 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
